The Future of Psychedelic Medicine
Using evidence-informed research, we want to unlock human performance and empower people to achieve their full potential.
Psychedelic medicine is the frontier of mental health and wellness
Social attitudes and behaviours towards mental health are shifting away from pharmaceuticals in favour of sustainably resourced compounds derived from fungi and plant medicines.
People globally are affected by a form of depression.
Dollars lost annually in global workforce productivity due to depression and anxiety.
Formulas standardized across clinical studies of psychedelic compounds.
HAVN Life is part of a global community taking an active role in formulations and research for microdosing therapies which have shown effectiveness in addressing mental health and performance.
Through the Partnership, the Company will seek Health Canada approval to supply naturally-derived psilocybin for legal and therapeutic use via the Special Access Program Vancouver, …
This new partnership will see the distribution of the Company’s standardized, naturally derived, psilocybin containing mushrooms for therapeutic use at Atman retreats in Jamaica Vancouver, …
The successful shipment of white label natural health products will expand the Company’s global retail footprint Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) …